259 related articles for article (PubMed ID: 17883171)
21. Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy.
Laurenti L; Tarnani M; Chiusolo P; La Torre G; Garzia M; Zollino M; Zini G; Balducci M; Leone G; Sica S
Clin Transplant; 2008; 22(2):191-9. PubMed ID: 18339139
[TBL] [Abstract][Full Text] [Related]
22. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
23. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
Friedberg JW
Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
[No Abstract] [Full Text] [Related]
24. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
25. Secondary lung tumors in hematological patients.
Amadori D; Ronconi S
Semin Respir Crit Care Med; 2005 Oct; 26(5):520-6. PubMed ID: 16267703
[TBL] [Abstract][Full Text] [Related]
26. Non-Hodgkin lymphoma secondary to cancer chemotherapy.
Krishnan B; Morgan GJ
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):377-80. PubMed ID: 17372233
[TBL] [Abstract][Full Text] [Related]
27. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
28. Acute myelogenous leukaemia following cytotoxic therapy: five cases and a review.
Smith AG; Prentice AG; Lucie NP; Browning JD; Dagg JH; Rowan RM
Q J Med; 1982; 51(202):227-40. PubMed ID: 6955825
[TBL] [Abstract][Full Text] [Related]
29. Nonbreast second malignancies after treatment of primary breast cancer.
Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
[TBL] [Abstract][Full Text] [Related]
30. Multiple primary cancers associated with hematological malignancies.
Nagura E; Kawashima K; Yamada K
Jpn J Clin Oncol; 1985 Apr; 15 Suppl 1():211-22. PubMed ID: 4009983
[TBL] [Abstract][Full Text] [Related]
31. [Second malignancies following radiotherapy: an analysis of 54 cases accumulated by mail survey in Japan].
Matsumoto Y; Nishimura T; Hirota S; Kanesaka N; Ogo E; Nakamura R; Monzen Y; Sakai K
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Jan; 62(1):27-31. PubMed ID: 11857951
[TBL] [Abstract][Full Text] [Related]
32. Adverse effects of cancer therapy. Risk of secondary neoplasms.
Coleman CN
Am J Pediatr Hematol Oncol; 1982; 4(1):103-11. PubMed ID: 7091571
[TBL] [Abstract][Full Text] [Related]
33. Second malignancies after treatment for Hodgkin's disease.
Várady E; Deák B; Molnár ZS; Rosta A; Schneider T; Esik O; Eckhardt S
Leuk Lymphoma; 2001; 42(6):1275-81. PubMed ID: 11911408
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members.
Padmanabhan A; Baker JA; Zirpoli G; Sait SN; Ford LA; Moysich KB; Baer MR
Leuk Res; 2008 Dec; 32(12):1820-3. PubMed ID: 18468682
[TBL] [Abstract][Full Text] [Related]
35. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease.
Hoppe RT
Leukemia; 1992 Nov; 6 Suppl 4():155-7. PubMed ID: 1434819
[No Abstract] [Full Text] [Related]
36. Early occurrence of acute myeloid leukemia following adjuvant radiotherapy and higher cumulative dose of cyclophosphamide in carcinoma breast.
Srivastava A; Murari M; Datta NR
Indian J Cancer; 2004; 41(4):178-80. PubMed ID: 15659873
[TBL] [Abstract][Full Text] [Related]
37. Second primary cancer due to radiotherapy and chemotherapy.
Manavoğlu O; Orhan B; Evrensel T; Karabulut Y; Ozkocaman V; Ozyardimci C
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):275-8. PubMed ID: 9216821
[TBL] [Abstract][Full Text] [Related]
38. Secondary hematological malignancies after treatment of non-metastatic breast cancer.
Arslan C; Ozdemir E; Dogan E; Ozisik Y; Altundag K
J BUON; 2011; 16(4):744-50. PubMed ID: 22331732
[TBL] [Abstract][Full Text] [Related]
39. Second malignancies following treatment in non-Hodgkin's lymphoma.
Ellis M; Lishner M
Leuk Lymphoma; 1993 Mar; 9(4-5):337-42. PubMed ID: 8348069
[TBL] [Abstract][Full Text] [Related]
40. Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
Costa LJ; Rodriguez V; Porrata LF; Lacy MQ; Elliott MA; Gertz MA; Gastineau DA; Litzow MR
Bone Marrow Transplant; 2008 Oct; 42(7):497-8. PubMed ID: 18622421
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
